Table 1.

Clinical characteristics of the patients included in this study.

Age, years	Sex	Duration of GO, months	CAS	fT4 (ng/dL)	TSH (mU/L)	TBII (%)	Previous treatment for GO
34	F	12	2	1.36	0.48	61.2	None
38	M	10	1	1.14	1.17	19.7	None
41	F	28	1	1.01	1.96	24.3	None
47	F	22	2	0.82	2.07	38.3	Oral steroids
57	F	20	1	1.09	1.39	54.2	None
58	M	36	2	0.91	0.57	44.5	Oral steroids

CAS, clinical activity score; fT4, free thyroxine; TSH, thyroid stimulating hormone; TBII, thyrotropin binding inhibitory immunoglobulin.